Dr. Kimmen Quan, Radiation Oncologist from the University of Pittsburgh Medical Center
Stations, the following is a news announcement. Suggested lead in 3, 2, 1…
(INTRO)
More than 11,000 of the world’s top cancer doctors and scientists gathered at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO) at the Moscone Center in San Francisco. This year’s theme for the four-day event, September 14-17, was “Targeting Cancer: Technology & Biology” and highlighted how technology and biology advance the field and improve patient outcomes and quality of life.
Dr. Kimmen Quan, a radiation oncologist from the University of Pittsburgh Medical Center, discusses his study on the effects of radiation therapy on patients with locally advanced pancreatic cancer.
(QUAN)
PATIENTS WHO HAVE THIS WILL BE OFFERED CHEMOTHERAPY FOLLOWED BY HIGH DOSE RADIATION, AND FOR THOSE PATIENTS WHO DON’T HAVE PROGRESSIVE DISEASE, THOSE PATIENTS WOULD BE OFFERED SURGERY. NOW THE HIGH DOSE RADIATION IS VERY TOLERABLE. WE DON’T HAVE MUCH IN TERMS OF TOXICITY AND THE HIGH DOSE RADIATION HELPS WITH A SUCCESSFUL SURGERY.
(CLOSE)
For more information, visit www.astro.org.